Is Celltrion Pharm, Inc. stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Celltrion Pharm, Inc. pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Wednesday 27th of December 2006 were paid KRW103.6879 per share. Over the last 1 times between 2006 and 2006, Celltrion Pharm, Inc. has paid KRW103.6879 with an average of KRW103.69 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Celltrion Pharm, Inc. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was KRW27 421, you would have made a profit of KRW39 379 per share or 143.60%
Yes, the average daily trading liquidity for Celltrion Pharm, Inc. is KRW217 777 thousand. You should therefore be able to get in and out of your positions relatively fast.
Celltrion Pharm, Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.09, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 4.16%, which is challenging.
We have calculated the inflation risk for Celltrion Pharm, Inc. to be medium [0.65 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.